Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024

セルベースアッセイの世界市場予測(~2024年)

◆タイトル:Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024
◆商品コード:BT-2486
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年4月10日
◆ページ数:133
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

セルベースアッセイの世界市場は、2019年の139億米ドルから2024年には189億米ドルに達し、この期間中6.3%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、研究資金の増加と創薬活動の活発化が考えられます。研究開発費の増加が見込まれる新興経済国もまた、市場の成長に貢献すると期待されています。当調査レポートでは、セルベースアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別(試薬、マイクロプレート、細胞株、アッセイキット、機器、サービス)分析、用途別(創薬、研究)分析、エンドユーザー別(CRO、バイオ医薬品会社、研究機関)分析、セルベースアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Cell-based assays market to register a CAGR of 6.3% from 2019 to 2024”
The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing research funding, and the growth in the number of drug discovery activities. Emerging economies with growing R&D expenditures are also expected to provide opportunities for the growth of the market.

“Services exhibited the highest CAGR over the forecast period.”
By product & service, the cell-based assays market is segmented into consumables, instruments and services. Over the forecast period, the services segment accounted for the highest CAGR. The increased R&D investments and technological innovations in supportive processes such as high-throughput screening is driving the growth of this product & service segment.

“Basic research held the significant share in the cell-based assays market in 2019”
On the basis of application, the cell-based assays market is segmented into drug discovery, basic research and other research such as quality check among others. In 2019, the drug discovery segment accounted for the largest share of the cell-based assays market. The large share of this segment can be attributed to the rising adoption of in vitro testing over animal testing and increasing in R&D spending by biopharmaceutical companies.

“Asia Pacific exhibited the highest CAGR over the forecast period”
North America, which includes the US and Canada, accounted for the largest share of the cell-based assays market. The large share of this market segment can be attributed to the increasing drug discovery activities by pharmaceutical and biotechnology companies. In addition to this, consolidations between academic and government institutes with biopharmaceutical companies in the region are also driving the growth of this market.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (35%), Europe (24%), Asia Pacific (25%), and RoW (16%)

Some of the major players in this market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).

Research Coverage
This report studies the cell-based assays market based on products, applications, end users, and regions. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell-based assays market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the cell-based assays offered by the top 10 players in the cell-based assays market. The report analyzes the cell-based assays market by product, , end user, application, and region
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various cell-based assays across key geographic regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-based assays market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell-based assays market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.2.1 MARKETS COVERED 16
1.2.2 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
1.4 LIMITATIONS 17
1.5 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1.1 SECONDARY DATA 19
2.1.1.1 Key Data from Secondary Sources 19
2.1.2 PRIMARY DATA 20
2.1.2.1 Key data from primary sources 21
2.2 MARKET SIZE ESTIMATION 21
2.2.1 BOTTOM-UP APPROACH 22
2.2.2 TOP-DOWN APPROACH 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.4 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 28
4.1 CELL-BASED ASSAYS: MARKET OVERVIEW 28
4.2 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE AND APPLICATION (2018) 29
4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL-BASED ASSAYS MARKET 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.2.1 DRIVERS 32
5.2.1.1 Growing preference for cell-based assays 32
5.2.1.2 Growing research funding 32
5.2.1.3 Growth in the number of drug discovery activities 32
5.2.2 RESTRAINT 33
5.2.2.1 High cost of instruments and restrictions on reagent use 33
5.2.3 OPPORTUNITIES 33
5.2.3.1 High-growth Asian countries 33
5.2.3.2 Application of novel cell-based assays in cancer research 34
6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE 35
6.1 INTRODUCTION 36
6.2 CONSUMABLES 37
6.2.1 REAGENTS 38
6.2.1.1 Reagents have widespread usage in life sciences due to their application in immunology research, disease research, and cancer diagnostics 38
6.2.2 ASSAY KITS 39
6.2.2.1 Reporter gene assays 40
6.2.2.1.1 Reporter gene assays can be used with limited resources for the establishment of HTS platforms, presenting opportunities for small laboratories with limited resources 40
6.2.2.2 Second messenger assays 41
6.2.2.2.1 Second messenger assays allow the detection and characterization of all compound classes—a key driver for market growth 41
6.2.2.3 Cell growth assays 42
6.2.2.3.1 Cell viability and cell proliferation assays are the two most important in vitro quantification techniques for assessing cell growth 42
6.2.2.4 Cell death assays 43
6.2.2.4.1 Cell death quantification is essential in drug development to identify the manner in which potential drugs could inhibit or enhance molecular targets—a key factor propelling market demand 43
6.2.2.5 Other assay kits 44
6.2.3 PROBES & LABELS 44
6.2.3.1 Effective labeling of cells helps in studying cellular events in a spatial and temporal context—a key factor driving the demand for probes and labels 44
6.2.4 MICROPLATES 45
6.2.4.1 Increasing demand for cell-based assays in drug discovery, basic research, and preclinical safety studies is encouraging the consumption of microplates 45
6.2.5 CELL LINES 46
6.2.5.1 Immortalized cell lines 47
6.2.5.1.1 Advantages of immortalized cell lines creating a demand for these cell lines over primary and stem cell lines 47
6.2.5.2 Primary cell lines 48
6.2.5.2.1 Primary cell lines are more sensitive as compared to immortalized cell lines—a key factor limiting market growth 48
6.2.5.3 Stem cell lines 49
6.2.5.3.1 Stem cell lines are alternative methodologies to address the cellularity issues that involve the directed differentiation of embryonic stem (ES) cells or induced pluripotent stem cells (iPS) 49
6.2.6 OTHER CONSUMABLES 50

6.3 INSTRUMENTS 50
6.3.1 BIOTECHNOLOGY COMPANIES AIM TO STREAMLINE THEIR WORKFLOWS TO IMPROVE PRODUCTIVITY AND REDUCE COSTS, WHICH WILL DRIVE THE GROWTH OF THE INSTRUMENTS MARKET 50
6.4 SERVICES 51
7 CELL-BASED ASSAYS MARKET, BY APPLICATION 53
7.1 INTRODUCTION 54
7.2 DRUG DISCOVERY 55
7.2.1 TOXICITY STUDIES 56
7.2.1.1 Increasing adoption of high-content screening for evaluating cytotoxicity is a factor stimulating the use of cell-based assays for toxicity studies 56
7.2.2 PHARMACOKINETIC STUDIES 57
7.2.2.1 Demand for ADME studies to rise due to the growing need for improved clinical success—a major factor driving growth 57
7.2.3 PHARMACODYNAMIC STUDIES 58
7.2.3.1 Increasing number of pharmacodynamics studies globally to drive growth in the cell-based assays market 58
7.3 BASIC RESEARCH 58
7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE THE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES 58
7.4 OTHER APPLICATIONS 59
8 CELL-BASED ASSAYS MARKET, BY END USER 61
8.1 INTRODUCTION 62
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 63
8.2.1 THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT IS PRIMARILY DRIVEN BY THE GROWTH IN THE NUMBER OF R&D ACTIVITIES 63
8.3 ACADEMIC & GOVERNMENT INSTITUTES 64
8.3.1 INCREASING INTEREST OF ACADEMIC INSTITUTIONS TO DEVELOP ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT 64
8.4 CONTRACT RESEARCH ORGANIZATIONS 65
8.4.1 GROWTH IN OUTSOURCING TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS 65
9 CELL-BASED ASSAYS MARKET, BY REGION 66
9.1 INTRODUCTION 67
9.2 NORTH AMERICA 68
9.2.1 US 71
9.2.2 CANADA 73

9.3 EUROPE 74
9.3.1 UK 76
9.3.2 GERMANY 78
9.3.3 FRANCE 80
9.3.4 REST OF EUROPE 81
9.4 ASIA PACIFIC 83
9.4.1 CHINA 85
9.4.2 JAPAN 87
9.4.3 INDIA 88
9.4.4 REST OF ASIA PACIFIC 90
9.5 REST OF THE WORLD 91
10 COMPETITIVE LANDSCAPE 93
10.1 OVERVIEW 93
10.2 MARKET RANKING ANALYSIS, 2017 94
10.2.1 CELL-BASED ASSAYS MARKET RANKING, BY KEY PLAYER, 2017 94
10.3 KEY STRATEGIES 95
10.3.1 PRODUCT LAUNCHES, 2015–2018 95
10.3.2 EXPANSIONS, 2015–2018 95
10.3.3 COLLABORATIONS, 2015–2018: 96
10.3.4 ACQUISITIONS, 2015–2018 96
10.4 COMPETITIVE LEADERSHIP MAPPING (2017) 97
10.5 VISIONARY LEADERS 97
10.6 INNOVATORS 97
10.6.1 DYNAMIC DIFFERENTIATORS 97
10.6.2 EMERGING COMPANIES 97
10.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017) 99
10.7.1 PROGRESSIVE COMPANIES 99
10.7.2 STARTING BLOCKS 99
10.7.3 RESPONSIVE COMPANIES 99
10.7.4 DYNAMIC COMPANIES 99
11 COMPANY PROFILES 101
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 THERMO FISHER SCIENTIFIC INC. 101
11.2 DANAHER CORPORATION 104
11.3 BECTON, DICKINSON AND COMPANY 107
11.4 GE HEALTHCARE 109
11.5 MERCK KGAA 111
11.6 LONZA GROUP LTD. 114
11.7 PERKINELMER, INC. 116
11.8 CHARLES RIVER LABORATORIES, INC. 119
11.9 CELL SIGNALING TECHNOLOGY, INC. 121
11.10 PROMEGA CORPORATION 122
11.11 CISBIO 124
11.12 CELL BIOLABS, INC. 125
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 126
12.1 INSIGHTS OF INDUSTRY EXPERTS 126
12.2 DISCUSSION GUIDE 127
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 129
12.4 AVAILABLE CUSTOMIZATIONS 131
12.5 RELATED REPORTS 131
12.6 AUTHOR DETAILS 132

LIST OF TABLES

TABLE 1 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 36
TABLE 2 CELL-BASED CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION) 37
TABLE 3 CELL-BASED CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 37
TABLE 4 CELL-BASED REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 38
TABLE 5 CELL-BASED ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION) 39
TABLE 6 CELL-BASED ASSAY KITS MARKET, BY REGION, 2017–2024 (USD MILLION) 39
TABLE 7 REPORTER GENE ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 40
TABLE 8 SECOND MESSENGER ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 41
TABLE 9 CELL GROWTH ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 42
TABLE 10 CELL DEATH ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 43
TABLE 11 OTHER ASSAY KITS MARKET, BY REGION, 2017–2024 (USD MILLION) 44
TABLE 12 CELL-BASED PROBES & LABELS MARKET, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 13 CELL-BASED MICROPLATES MARKET, BY REGION, 2017–2024 (USD MILLION) 46
TABLE 14 CELL LINES MARKET, BY TYPE, 2017–2024 (USD MILLION) 46
TABLE 15 CELL LINES MARKET, BY REGION, 2017–2024 (USD MILLION) 47
TABLE 16 IMMORTALIZED CELL LINES MARKET, BY REGION, 2017–2024 (USD MILLION) 48
TABLE 17 PRIMARY CELL LINES MARKET FOR, BY REGION, 2017–2024 (USD MILLION) 49
TABLE 18 STEM CELL LINES MARKET, BY REGION, 2017–2024 (USD MILLION) 49
TABLE 19 OTHER CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 20 CELL-BASED INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 51
TABLE 21 CELL-BASED ASSAY SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 52
TABLE 22 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 54
TABLE 23 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY REGION,
2017–2024 (USD MILLION) 55
TABLE 24 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY TYPE,
2017–2024 (USD MILLION) 55
TABLE 25 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION,
2017–2024 (USD MILLION) 56
TABLE 26 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 27 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2017–2024 (USD MILLION) 58
TABLE 28 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION,
2017–2024 (USD MILLION) 59
TABLE 29 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 60
TABLE 30 CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 62
TABLE 31 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION) 63
TABLE 32 CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES,
BY REGION, 2017–2024 (USD MILLION) 64
TABLE 33 CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2017–2024 (USD MILLION) 65
TABLE 34 CELL-BASED ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 68
TABLE 35 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 70
TABLE 36 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017–2024 (USD MILLION) 70
TABLE 37 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 70
TABLE 38 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 71
TABLE 39 US: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES,
2017–2024 (USD MILLION) 72
TABLE 40 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 72
TABLE 41 US: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 72
TABLE 42 CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES,
2017–2024 (USD MILLION) 73
TABLE 43 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 74
TABLE 44 CANADA: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 74
TABLE 45 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 75
TABLE 46 EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERIVECS,
2017–2024 (USD MILLION) 75
TABLE 47 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 76
TABLE 48 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 76
TABLE 49 UK: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES,
2017–2024 (USD MILLION) 77
TABLE 50 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 77
TABLE 51 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 77
TABLE 52 GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES,
2017–2024 (USD MILLION) 78
TABLE 53 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 79
TABLE 54 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 79
TABLE 55 FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 80
TABLE 56 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 80
TABLE 57 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 81
TABLE 58 ROE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 81
TABLE 59 ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 82
TABLE 60 ROE: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 82
TABLE 61 APAC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 84
TABLE 62 APAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 84
TABLE 63 APAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 84
TABLE 64 APAC: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 85
TABLE 65 CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 86
TABLE 66 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 86
TABLE 67 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 86
TABLE 68 JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 87
TABLE 69 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 88
TABLE 70 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 88
TABLE 71 INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 89
TABLE 72 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 89
TABLE 73 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 89
TABLE 74 ROAPAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 90
TABLE 75 ROAPAC: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 90
TABLE 76 ROAPAC: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION) 91
TABLE 77 ROW: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 91
TABLE 78 ROW: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 92
TABLE 79 ROW: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION) 92


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 18
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 20
FIGURE 3 CELL-BASED ASSAYS MARKET: BOTTOM-UP APPROACH 22
FIGURE 4 CELL-BASED ASSAYS MARKET: TOP-DOWN APPROACH 22
FIGURE 5 DATA TRIANGULATION METHODOLOGY 23
FIGURE 6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2019 VS. 2024 (USD MILLION) 25
FIGURE 7 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 26
FIGURE 8 CELL-BASED ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 26
FIGURE 9 CELL-BASED ASSAYS MARKET, BY REGION, 2019 VS. 2024 (USD MILLION) 27
FIGURE 10 GROWTH IN THE NUMBER OF DRUG DISCOVERY ACTIVITIES IS DRIVING THE DEMAND FOR CELL-BASED ASSAYS 28
FIGURE 11 DRUG DISCOVERY APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF
THE CELL-BASED ASSAYS MARKET IN 2018 29
FIGURE 12 COUNTRIES IN APAC TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD 30
FIGURE 13 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 31
FIGURE 14 CONSUMABLES TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING
THE FORECAST PERIOD 36
FIGURE 15 DRUG DISCOVERY APPLICATIONS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 54
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ESTIMATED TO BE THE LARGEST END USERS OF CELL-BASED ASSAYS DURING THE FORECAST PERIOD 62
FIGURE 17 NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET 67
FIGURE 18 NORTH AMERICA: CELL-BASED ASSAY MARKET SNAPSHOT 69
FIGURE 19 APAC: CELL-BASED ASSAYS MARKET SNAPSHOT 83
FIGURE 20 KEY DEVELOPMENTS IN THE CELL-BASED ASSAYS MARKET FROM 2015 TO 2019 93
FIGURE 21 MNM DIVE-VENDOR COMPARISON MATRIX: CELL-BASED ASSAYS MARKET 98
FIGURE 22 MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: CELL-BASED
ASSAYS MARKET 100
FIGURE 23 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2017) 101
FIGURE 24 DANAHER CORPORATION: COMPANY SNAPSHOT (2018) 104
FIGURE 25 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018) 107
FIGURE 26 GE HEALTHCARE: COMPANY SNAPSHOT (2018) 109
FIGURE 27 MERCK KGAA: COMPANY SNAPSHOT (2017) 111
FIGURE 28 LONZA GROUP LTD.: COMPANY SNAPSHOT (2017) 114
FIGURE 29 PERKINELMER, INC.: COMPANY SNAPSHOT (2018) 116
FIGURE 30 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2017) 119


★調査レポート[セルベースアッセイの世界市場予測(~2024年)] ( Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024 / BT-2486) 販売に関する免責事項
[セルベースアッセイの世界市場予測(~2024年)] ( Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024 / BT-2486) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆